Light therapy could replace surgery for rare urinary tract cancer
NCT ID NCT04620239
First seen Feb 04, 2026 · Last updated May 08, 2026 · Updated 13 times
Summary
This study tests a drug called TOOKAD (padeliporfin) that is activated by light to destroy low-grade tumors in the kidney or ureter. About 100 adults with this rare cancer will receive the treatment in two phases and be followed for up to 4 years. The goal is to see if the drug can clear all visible tumors without needing surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSITIONAL CELL CANCER OF RENAL PELVIS AND URETER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Albany Medical College
RECRUITINGAlbany, New York, 12208, United States
Contact
-
CHU de Lille - Hopital Claude Huriez
RECRUITINGLille, 59037, France
Contact
-
Carolina Urologic Research Center
RECRUITINGMyrtle Beach, South Carolina, 29572, United States
Contact
-
Emory University Hospital
RECRUITINGAtlanta, Georgia, 30322, United States
Contact
-
HCL Hopital Edouard Herriot
RECRUITINGLyon, 69437, France
Contact
-
Hospital Universitario Vall d'Hebron
RECRUITINGBarcelona, 08035, Spain
Contact
-
Hospital Universitario de A Coruña
RECRUITINGA Coruña, 15006, Spain
Contact
-
Keck School of Medicine at USC Medical Center
RECRUITINGLos Angeles, California, 90033, United States
Contact
-
Medical University of South Carolina (MUSC)
RECRUITINGCharleston, South Carolina, 29425, United States
Contact
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
Contact
Contact
-
Sheba Medical Center
RECRUITINGRamat Gan, Israel
Contact
-
The Johns Hopkins Hospital, The Sidney Kimmel Cancer Center
RECRUITINGBaltimore, Maryland, 21287, United States
Contact
-
The Ohio State University (OSU)
RECRUITINGColumbus, Ohio, 43210, United States
Contact
-
The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center
RECRUITINGHershey, Pennsylvania, 17033, United States
Contact
-
Universitaetsklinikum Tuebingen
RECRUITINGTübingen, 72076, Germany
Contact
-
University of California - Irvine Medical Center
RECRUITINGIrvine, California, 92868, United States
Contact
-
University of Texas Southwestern
RECRUITINGDallas, Texas, 75390, United States
Contact
-
University of Washington
RECRUITINGSeattle, Washington, 98195, United States
Contact
Conditions
Explore the condition pages connected to this study.